Blue Venture Fund

The Blue Venture Fund is a corporate venture fund established as a collaboration among Blue Cross Blue Shield (BCBS) companies, the Blue Cross Blue Shield Association, and Sandbox Industries. It focuses on investing in healthcare-related startups to drive innovation and improve health outcomes. The fund has committed over $890 million across four funds, supporting emerging companies in healthcare technology, services, and clinical sciences. Through this collaboration, the Blue Venture Fund aims to advance the healthcare industry by investing in technology, services, and clinical sciences companies to drive better health outcomes and deliver superior value to patients. The fund partners with market-leading CEOs to provide strategic guidance, partnership introductions, strategic sales support, and Board oversight. The fund team has well-established programs for introducing portfolio companies to Blue Plans to drive significant revenue, distribution, and partnership opportunities. Plans have access to innovative companies that can lead to business development and strategy insights, vendor agreements, or M&A opportunities. The unrivaled market position of The Blues® and unparalleled recognition of the Blue Cross and Blue Shield brands attracts best-in-class emerging companies. The fund is stage-agnostic, investing in emerging companies from seed to growth to buyout. The fund's focus is on three sub-sectors of healthcare with the goal of reducing cost and improving health outcomes for Blue Plan Members: Healthcare Services, Healthcare Technology, and Clinical Sciences. The fund emphasizes relationship building and focuses on helping entrepreneurs, recognizing the challenges of building a business, especially in healthcare. Through the BVF platform, Blue Plans gain access to technologies, innovations, and solutions through the portfolio companies and pipeline opportunities. The strategic engagement model connects portfolio companies to the knowledge and expertise of Blue Plan partners—who are looking to innovate and collaborate with early-stage companies—as well as to the needs and priorities of Blue Plan Members. This dual focus ensures that the innovations supported are not only commercially viable but also meaningfully improve the healthcare experience for Blue Plan Members.